RING - Rituximab for Lupus Nephritis With Remission as a Goal
Status:
Unknown status
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
OBJECTIVE To test whether Rituximab (RTX) is efficacious to achieve complete renal response
(CR) in Lupus Nephritis (LN) patients with persistent proteinuria (≥1g/d) despite at least 6
months of standard of care (SOC).
STUDY DESIGN Investigator-initiated randomized international open multicentric 104-week
study.